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ABSTRACT
Background: In this prospective, randomized, double-
blind study, we compared the efficacy of ondansetron
versus dehydrobenzoperidol (droperidol) or metoclo-
pramide in the treatment of established postoperative
nausea and vomiting in 200 adult patients undergoing
laparoscopic surgery under general anesthesia. 
Methods: One hundred seventy-three American Society
of Anesthesiologists (ASA) I and II patients satisfied
inclusion criteria. Fifty-seven patients received
ondansetron 4 mg (group O), 57 patients were given
droperidol 1.25 mg (group D), and 59 patients received
metoclopramide 10 mg (group M). Antiemetic efficacy
was compared at 10 minutes and 30 minutes after the
administration of the study drug. 
Results: At 10 minutes, nausea scores in group O
dropped from 8.3 to 3.7, in group D from 8.5 to 5, and
in group M from 8.4 to 6.7; (P < 0.05 between the three
groups). At 30 minutes, nausea scores were 1.3 in group
O, 1.7 in group D, and 5 in group M; (P < 0.05 between
group M and the other two groups). In the droperidol
group, 25% of patients developed sedation. Patient satis-
faction was best with ondansetron.
Conclusions: Both ondansetron and droperidol were
more effective in the treatment of established postopera-
tive nausea and vomiting than was metoclopramide.
However, patients were satisfied best with ondansetron,
which acts faster and causes less sedation than droperi-
dol. 
Key Words: Postoperative nausea and vomiting,
Laparoscopic surgery, Antiemetics, Ondansetron,
Dehydrobenzoperidol, Metoclopramide.
INTRODUCTION
Postoperative nausea and vomiting (PONV) are of major
concern to patients undergoing surgery under both gen-
eral and regional anesthesia;1 they can delay hospital dis-
charge,2 and even result in overnight hospital admission
to outpatient surgery.3 The incidence of postlaparoscop-
ic vomiting is 35%.4,5 Ondansetron has been shown to be
effective and well tolerated in the treatment of PONV.6,7
Ondansetron 4 mg has been shown to be the optimal
dose.8 In the treatment of postoperative nausea and vom-
iting, ondansetron has also been shown to be superior to
metoclopramide;9,10 however, it has been shown to be
similar to dehydrobenzoperidol (droperidol).11,12
No previous report that compares the three drugs togeth-
er for the treatment of established PONV exists in the lit-
erature. The purpose of this study is to compare the
antiemetic efficacy of ondansetron versus droperidol and
metoclopramide in the treatment of established PONV in
patients undergoing laparoscopic surgery.
METHODS
The institutional research committee approved this study,
and the patients provided informed consent. American
Society of Anesthesiologists (ASA) Class I and II patients
undergoing laparoscopic surgery who developed post-
operative nausea and vomiting were chosen. A total of
200 patients were enrolled in the study. Patients receiv-
ing pre- or intraoperative antiemetics were excluded.
Also, exclusion criteria included postoperative pain
scores > 5, patients who received postoperative nar-
cotics, pregnant females, patients with a nasogastric tube
remaining postoperatively, and sedation scores > 1. The
degree of sedation was assessed as 1 = awake, 2 =
drowsy, 3 = asleep.
One hundred seventy-three patients satisfied inclusion
criteria. The following data were collected on all patients:
age, weight, sex, history of diabetes and motion sickness,
history of PONV, and type of operation, duration of sur-
gery and anesthetic technique. The patients were divid-
ed into 3 groups. A random number was used to assign
patients prospectively into one of the three treatment
medications: ondansetron 4 mg, droperidol 1.25 mg, and
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metoclopramide 10 mg, in 2 mL solution. Fifty-seven
patients received ondansetron (group O), 57 patients
were given droperidol (group D), and 59 patients
received metoclopramide (group M). The staff caring for
these patients were blinded to the study drug received.
Vital signs were recorded following each medication.
All patients were premedicated with glycopyrrolate 0.2
mg IM and diazepam 5 mg PO 45 minutes prior to the
induction of anesthesia. After standard monitoring (EKG,
noninvasive blood pressure, and oximetry) was applied,
anesthesia was induced in the three groups with propo-
fol 2mg/kg, fentanyl 2-3 ug/kg, and vecuronium 0.1
mg/kg. Anesthesia was then maintained by isoflurane
and supplementary doses of vecuronium. The duration
of the operation was recorded, and neuromuscular
blockade was reversed at the end of surgery by a mix-
ture of neostigmine 0.05 mg/kg and atropine 0.02 mg/kg.
In the recovery room and upon the complaint of nausea,
vomiting, or both, assessment of the degree of nausea
was made subjectively by the patient using an 11 point
(0 to 10) rating score. A score of 10 corresponded to
worst possible nausea, vomiting, or both. An independ-
ent blinded observer gave one of the three study med-
ications and recorded vital signs, oxygen saturation, and
the nausea scores at 10 minutes and 30 minutes follow-
ing the administration of the three study groups. Also
side effects, such as sedation, headache, dizziness, and
agitation, were noted. Patients who continued vomiting
following use of the three study drugs were given meto-
clopramide 10 mg as rescue antiemetics. After 2 hours,
inpatients were discharged to the floor, where they were
followed up for 24 hours by another independent
observer; nausea score, vomiting, pain, and medications
were recorded. The time for discharge of outpatients
from the recovery room was also recorded.
Patient satisfaction (yes or no) was based on a question-
naire that included degree of nausea relief, side effects,
and recommendations for future use.
Statistical analysis of data among the three groups was
performed by the ANOVA test for nausea scores and
recovery room stay and the chi-square test for rescue
antiemetic use. A P value < 0.05 was considered signifi-
cant for both tests.
RESULTS
No significant difference between the study groups exist-
ed with respect to the age, sex, weight, history of motion
sickness, history of postoperative nausea and vomiting,
diabetes, duration of operation and type of operation
between the three groups (Table 1). 
Table 1.
Demographic Data.
Ondansetron Droperidol Metoclopramide
N5 7 5 7 5 9
Sex: Female 45 45 44
Male 11 12 15
Weight: Female 69.1 +/- 12.1 68.3 +/- 10.2 70.2 +/- 13.8
Male 87.6 +/- 18.9 85.2 +/- 17.2 89.7 +/- 19.1
Motion Sickness 5 1 3
PONV 16 14 16
Diabetic 3 2 1
Age 46 +/- 17.6 44 +/- 16.2 42 +/- 18.3
Duration of Operation 90.2 +/- 23.3 80.6 +/- 20.6 85 +/- 19.3
Laparoscopic Cholecystectomy 30 32 33
Laparoscopic Herniorrhaphy 6 2 4
Laparoscopic Appendectomy 5 7 5
Diagnostic Laparoscopy 15 16 17As shown in Figure 1, both ondansetron and droperidol
lowered the nausea score significantly better than meto-
clopramide did at 10 minutes and 30 minutes (P < 0.05).
However, at 10 minutes, ondansetron, lowered the nau-
sea score significantly better than droperidol did. (P <
0.05).
As shown in Figure 2, out of the 57 patients who
received ondansetron, 5 maintained vomiting that need-
ed a rescue antiemetic (metoclopramide 10 mg). Out of
the 57 patients who received droperidol, 6 maintained
vomiting that needed a rescue antiemetic. Also, out of
the 59 patients who received metoclopramide, 25 main-
tained nausea, vomiting, or both that needed the rescue
antiemetic. A statistical difference (P < 0.05) existed
between the metoclopramide group and the other two
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groups, but no difference was noted between the
ondansetron group and the droperidol group.
As shown in Table 2, 25% of patients (14/57) in the
droperidol group had sedation, (sedation score = 3), but
no sedation was observed in the other two groups. All
other side effects (headache, dizziness, malaise, and agi-
tation) were similar among the three groups.
Also, the average time for discharge from the recovery
room was 170 minutes +/- 30 for group O, 250+/- 55 for
group D, and 210+/- 50 for group M. A significant differ-
ence existed between the three groups (P < 0.05). Patient
satisfaction was best with ondansetron 82%, metoclo-
pramide 65%, and droperidol 59%. 
DISCUSSION
Postoperative nausea and vomiting are multifactorial in
origin. Patient-controlled factors like age, sex, obesity,
history of motion sickness, history of previous PONV and
diabetes exist. Surgical factors like type of surgery, dura-
tion of surgery, type of anesthesia, along with postoper-
ative pain or analgesia (narcotics) contribute to its etiol-
ogy.1 In this study, however, the treatment groups were
similar with regards to patient demographics, surgical
procedure, anesthetics administered, and analgesics
Therefore, the response to the different treatment drugs
can be attributed to the antiemetic drug administered. 
Figure 1. Nausea scores at 10 and 30 minutes versus the control
score in patients who received O (Ondansetron), D (Droperidol)
and M (Metoclopramide).
Figure 2. Number of patients who received rescue antiemetics
(Metoclopramide 10 mg IV push) versus total number of 
patients in the O (Ondansetron), D (Droperidol) and M
(Metoclopramide) groups. 
Table 2.
Side Effects.
Ondansetron Droperidol Metoclopramide
Sedation 0 14 (25%) 0
Headache 8 (14%) 6 (10%) 5 (8%)
Dizziness 7 (12%) 6 (10%) 6 (10%)
Malaise 7 (12%) 10 (17%) 6 (10%)
Agitation 2 (4%) 3 (5%) 3 (5%)
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The antiemetic mechanism can be either central or
peripheral. Drugs used for the treatment of PONV are
usually antihistaminics, anticholinergics, dopamine recep-
tor antagonists, and 5HT3 antagonists.1 The present study
is the only report that compares the three drugs
ondansetron, droperidol, and metoclopramide for the
treatment of PONV. Our results show that both
ondansetron 4 mg and droperidol 1.25 mg are more
effective than metoclopramide 10 mg in the treatment of
established postoperative nausea and vomiting in patients
undergoing laparoscopic surgery. Although the nausea
score at 30 minutes shows no significant difference
between group O and group D, the nausea score analy-
sis at 10 minutes shows that ondansetron is better than
droperidol. In addition, droperidol 1.25 mg caused a 25%
incidence of sedation and a longer stay in the recovery
room for outpatient surgery.
In conclusion, we have shown that ondansetron 4 mg
and droperidol 1.25 mg are more effective than 10 mg
metoclopramide in the treatment of established PONV in
adult patients undergoing laparoscopic surgery. However,
droperidol was significantly less effective at 10 minutes
than ondansetron is at decreasing nausea scores. Also,
droperidol was followed by sedation associated with a
prolonged recovery room stay.
Therefore, the use of ondansetron is recommended in
outpatient surgery.
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